Recently, evidence demonstrated that different PRDX4 expression levels in tumor tissues were closely associated with the prognosis of cancer patients, indicating this antioxidant enzyme played important roles in the initiation and progression of cancer 20, 21. This evidence concerns the gene PRDX4 and neoplasm.